Join to View Full Profile
9000 Stony Point PkwyRichmond, VA 23235
Phone+1 804-560-8921
Fax+1 804-560-8992
Dr. Sime is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Edinburg Medical SchoolClass of 1988
University of Texas Southwestern Medical CenterFellowship, Maternal-Fetal Medicine
Certifications & Licensure
VA State Medical License 2019 - 2026
NY State Medical License 2001 - 2021
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Elected Member The American Society for Clinical Investigation, 2009
Publications & Presentations
PubMed
- Piezo2 Is a Key Mechanoreceptor in Lung Fibrosis that Drives Myofibroblast Differentiation.Margaret A T Freeberg, Sarah V Camus, Valentina Robila, Apostolos Perelas, Thomas H Thatcher
The American Journal of Pathology. 2025-04-01 - Ablation of LRP6 in alpha-smooth muscle actin-expressing cells abrogates lung inflammation and fibrosis upon bleomycin-induced lung injury.Eun-Ah Sung, Mikhail G Dozmorov, SuJeong Song, Theingi Aung, Min Hee Park
FEBS Letters. 2025-01-28 - Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to theSpecial Issue on ILD (Part 2).Anna J Podolanczuk, Toby M Maher, Wonder P Drake, Patricia J Sime, Oliver Eickelberg
American Journal of Respiratory and Critical Care Medicine. 2024-08-15
Press Mentions
Blocking Piezo2 Protein Receptor May Slow IPF Progression: StudyApril 4th, 2025- Study Identifies Novel Pathway with Potential to Slow the Progression of Pulmonary FibrosisMarch 25th, 2025
- Persistent Pandemics: Alum Lung Researcher Studies Long-Term Impacts for Global HealthMarch 16th, 2023
- Join now to see all
Grant Support
- Novel oral small molecules for progressive pulmonary fibrosisNOVOMEDIX, INC.2024–2025
- Role Of The Aryl Hydrocarbon Receptor In Lung InflammationNational Heart, Lung, And Blood Institute2008–2012
- Pathways To FibrosisNational Heart, Lung, And Blood Institute2008–2009
- Modulation Of Silica-Induced Pulmonary FibrosisNational Heart, Lung, And Blood Institute2005–2009
- TGFB And Gene Therapy In Silica Induced Lung FibrosisNational Heart, Lung, And Blood Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
